Primary Causes & Pathophysiology
Malignant pleural effusions develop through several mechanisms depending on the tumour type. Direct pleural infiltration by tumour nodules increases capillary permeability and impairs lymphatic stomata drainage, leading to exudative fluid accumulation. Central lymphatic obstruction by mediastinal lymphadenopathy can also decrease pleural fluid clearance. Additionally, tumour-derived inflammatory cytokines (such as VEGF) promote vascular leakiness, while impaired venous return due to superior vena cava obstruction may contribute to a transudative component in some cases. The net result is an imbalance between fluid production and clearance, causing symptomatic compression of the underlying lung.
Direct extension or metastatic spread to the visceral and parietal pleura causes local inflammation, increased vascular permeability, and lymphatic obstruction.
Haematogenous or lymphatic metastasis to the pleura and mediastinal nodes impairs fluid clearance and promotes exudation.
Mediastinal lymphadenopathy obstructs central pleural lymphatic drainage; direct pleural involvement may also occur.
Peritoneal fluid tracks through diaphragmatic defects into the pleural space, or direct pleural metastases occur.
Transdiaphragmatic lymphatic spread or direct peritoneal-pleural tracking of malignant cells.